Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas
收藏DataMed2026-07-12 收录
官方服务：
资源简介：
A Phase I/Ib, Study to Evaluate Safety and Efficacy of RP4010, in Patients with Relapsed or Refractory Lymphomas
提供机构：
ClinicalTrials.gov
